Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:

Comment by tamaracktopon Jan 11, 2023 7:53pm

RE:Dr. Peter Dicpinigaitis Appointed to the Advisory Board

He looks very much like a young Gene Hackman.

Discussion

Comment by C10H12N2on Jan 11, 2023 6:22pm

RE:Dr. Peter Dicpinigaitis Appointed to the Advisory Board

Yes, the good doctor has world class credentials. However, the bottomline goes something like this: When does/will the trial actually start? In how many different countries will they ...more

108

Discussion

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 23, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Comment by waves1on Jan 11, 2023 3:09pm

RE:Dr. Peter Dicpinigaitis Appointed to the Advisory Board

Definitely. It's notable that while he has extensive experience in all aspects of clinical medicine, a major focus of his clinical research for over 25 years has been in the area of cough ...more

Discussion

Post by Justdosomeddon Jan 11, 2023 1:26pm

Dr. Peter Dicpinigaitis Appointed to the Advisory Board

It’s important for a company to have a strong advisory board to help guide them toward the right path. $AGN.C just appointed Dr. Peter Dicpinigaitis to the board, and he certainly has the ...more

172

Discussion

(0)
•••

Post by PressReleaseon Jan 11, 2023 7:00am

New Press Release - Algernon Pharmaceuticals Appoints Dr. Peter Dicpinigaitis to Chronic Cough Advisory Board

VANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has appointed Dr. Peter...read article.

Post by stockpatrolon Jan 10, 2023 5:45pm

$AGN.c releases phase 2b details of the chronic cough study

$AGN.c releases phase 2b details of the chronic cough study of Ifenprodil. https://www.youtube.com/watch?v=REtP6b3LwY0&ab_channel=Proactive $AGN.c has announced it is ...more

157

Comment by C10H12N2on Jan 10, 2023 4:55pm

RE:RE:RE:RE:Real World Math Doesn't Apply To Algernon Pharmaceuticals

My apology for the name calling. Follow-up for "arguments" sake. Let's say you are right about rhe likely explained to you by management interpretation of the SEC filing news release ...more

Discussion

Comment by C10H12N2on Jan 10, 2023 4:29pm

RE:RE:RE:RE:Real World Math Doesn't Apply To Algernon Pharmaceuticals

Dude, does 2+2=4 in your world? The math doesn't lie. You can't get to a 10M dollar raise of a subsidiary valued at 20M without offering 50% of all shares. What you claim to be an argument is ...more

Discussion

Post by waves1on Jan 10, 2023 4:05pm

AGN CEO discussing Phase 2b of ifenprodil for chronic cough

Check out AGN's CEO Christopher Moreau on Proactive ...more

130

Comment by waves1on Jan 10, 2023 4:01pm

RE:Potential for ODD w/ Phase2b chronic cough study?

AGN trading green today following this news!

Discussion

Comment by nodaytraderon Jan 10, 2023 2:14pm

RE:RE:RE:Real World Math Doesn't Apply To Algernon Pharmaceuticals

Argument should never debate with invective. Over and out!

Discussion

(0)
•••

Post by PressReleaseon Jan 10, 2023 2:00pm

New Press Release - Algernon Pharmaceuticals releases details of Phase 2b chronic cough study of Ifenprodil

(NewsDirect)Algernon Pharmaceuticals CEO Christopher Moreau shared news that the company has announced it is planning a 180 patient, 3-month, Phase 2b clinical study of Ifenprodil for chronic cough. The study is set to begin in Q3 of 2023 and follows positive feedback from the US FDA at its pre...read article.

Comment by C10H12N2on Jan 10, 2023 12:42pm

RE:RE:Real World Math Doesn't Apply To Algernon Pharmaceuticals

Some people will always be morons no matter how much they're shown the way.

Discussion

Comment by nodaytraderon Jan 10, 2023 11:16am

RE:Real World Math Doesn't Apply To Algernon Pharmaceuticals

The $20 valuation is based on comparables at Stage 1 research while the cash call occurs at Stage 2. if Stage 2 results mirror Stage 1, there will be a massive increase in imputed ...more

Discussion

Post by StockHawk1on Jan 09, 2023 3:33pm

AGN featured in The Power Play by The Market Herald

The Power Play by The Market Herald just released this interview with Algernon Pharmaceuticals (AGN.c AGNPF) where they discuss their plans for a Phase 2b clinical study of their Ifenprodi drug for ...more

145

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (CSE:AGN)